(arstechnica.com): The scientific community has always had difficulty policing conflicts of interest, since financial interests and other exterior motivations have a very real potential to influence if and how scientific data gets reported. This issue has historically reared its ugly head in the biomedical community, where many researchers also consult for the pharmaceutical and biotechnology industries.
Category: Articles
Click here